These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36156755)

  • 21. [Bone and calcium metabolism associated with malignancy. Tumor-induced osteomalacia.].
    Fukumoto S
    Clin Calcium; 2018; 28(11):1451-1455. PubMed ID: 30374000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
    Ito N; Shimizu Y; Suzuki H; Saito T; Okamoto T; Hori M; Akahane M; Fukumoto S; Fujita T
    J Intern Med; 2010 Oct; 268(4):390-4. PubMed ID: 20698924
    [No Abstract]   [Full Text] [Related]  

  • 23. Paraneoplastic Secretion of Multiple Phosphatonins From a Deep Fibrous Histiocytoma Causing Oncogenic Osteomalacia.
    Leow MKS; Dogra S; Ge X; Chuah KL; Liew H; Loke KSH; McFarlane C
    J Clin Endocrinol Metab; 2021 Apr; 106(5):e2299-e2308. PubMed ID: 33462615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumor-induced hypophosphatemic osteomalacia].
    Ito N; Fukukmoto S
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
    Nasu T; Kurisu S; Matsuno S; Tatsumi K; Kakimoto T; Kobayashi M; Nakano Y; Wakasaki H; Furuta H; Nishi M; Sasaki H; Suzuki H; Ito N; Fukumoto S; Nanjo K
    Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-induced osteomalacia.
    Jan de Beur SM
    JAMA; 2005 Sep; 294(10):1260-7. PubMed ID: 16160135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
    Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
    Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
    [No Abstract]   [Full Text] [Related]  

  • 29. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
    Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
    J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor induced osteomalacia: A single center experience on 17 patients.
    Crotti C; Bartoli F; Coletto LA; Manara M; Marini E; Daolio PA; Parafioriti A; Armiraglio E; Zucchi F; Sinigaglia L; Caporali R; Varenna M
    Bone; 2021 Nov; 152():116077. PubMed ID: 34175499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases.
    Bosman A; Palermo A; Vanderhulst J; De Beur SMJ; Fukumoto S; Minisola S; Xia W; Body JJ; Zillikens MC
    Calcif Tissue Int; 2022 Oct; 111(4):367-379. PubMed ID: 35857061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-induced osteomalacia (TIO).
    Molendowska A; Jakubowska J; Jędrzejuk D; Szymczak J
    Endokrynol Pol; 2022; 73(5):903-904. PubMed ID: 36621920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oncogenic osteomalacia and its symptoms: hypophosphatemia, bone pain and pathological fractures].
    Kaniuka-Jakubowska S; Biernat W; Sworczak K
    Postepy Hig Med Dosw (Online); 2012 Aug; 66():554-67. PubMed ID: 22922156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y; Fukumoto S
    Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: A case report.
    Oe Y; Kameda H; Nomoto H; Sakamoto K; Soyama T; Cho KY; Nakamura A; Iwasaki K; Abo D; Kudo K; Miyoshi H; Atsumi T
    Medicine (Baltimore); 2021 Nov; 100(46):e27895. PubMed ID: 34797338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2006 Jun; Suppl 2():96-9. PubMed ID: 16817359
    [No Abstract]   [Full Text] [Related]  

  • 39. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
    Westerberg PA; Linde T; Ljunggren O
    Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
    [No Abstract]   [Full Text] [Related]  

  • 40. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
    Imel EA; Peacock M; Pitukcheewanont P; Heller HJ; Ward LM; Shulman D; Kassem M; Rackoff P; Zimering M; Dalkin A; Drobny E; Colussi G; Shaker JL; Hoogendoorn EH; Hui SL; Econs MJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2055-61. PubMed ID: 16551733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.